MapLight Therapeutics MPLT
NASDAQ MPLT
$8.24 +0.24 (+3.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) EBITDA (2024 - 2025)

Updated

MapLight Therapeutics (MPLT) reported EBITDA of -$83.22 million for Q4 2025, compared with -$22.58 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) EBITDA (2024 - 2025) Analysis & Trends

For FY2025, MapLight Therapeutics posted EBITDA of -$168.48 million.

  • By year, EBITDA came in at -$82.25 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.10 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 8.33 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -9.70 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 5.89 Bn
10 MapLight Therapeutics 374.35 Mn 374.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -83.22 Mn
Sep 30, 2025 -31.40 Mn
Dec 31, 2024 -22.58 Mn
Sep 30, 2024 -20.69 Mn
API Access

MapLight Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=MPLT&period=max&api_key=YOUR_API_KEY